Company: HSDTW
Filing Date: 2025-03-14
Form Type: PRE 14A
Source: 0001558370-25-003007
Chunk: 36

Company: Solana Co
Filing Date: 2025-03-14
Form: PRE 14A
Chunk 36
---
 by Dr. Favit-Van Pelt for good reason, the exercise by the Company of its right to terminate her employment other than for cause, death or disability or the Company’s election not to extend the employment period upon expiration of the Initial Term or any Renewal Term, in each case, within twelve months following or three months prior to the effective date of a Change in Control, Dr. Favit-Van Pelt shall receive (i) the Unconditional Entitlements, (ii) 1.5 times the sum of her annual base salary and target cash bonus, (iii) accelerated vesting of all equity awards that were assumed, continued or substituted by the surviving or acquiring corporation in the Change in Control and remain subject to time-based vesting conditions, if any, and (iv) the Conditional Benefits except the severance amount. During employment and for the one year period after termination, Dr. Favit-Van Pelt is subject to non-solicitation and non-competition requirements. Equity Incentive Plans Certain of our named executive officers have outstanding awards under (i) the 2018 Omnibus Incentive Plan (the “ 2018 Plan”), (ii) the 2022 Plan and (iii) the 2021 Inducement Plan (the “ Inducement Plan”, and together with the 2018 Plan and the 2022 Plan, the “ Plans”). Under the 2018 Plan and the 2022 Plan, the Compensation Committee may provide, in individual award agreements or in any other written agreement between a participant and the company that the award will be subject to additional acceleration of vesting and exercisability in the event of a termination of employment or change in control. Under the Inducement Plan, an award may be subject to additional acceleration of vesting and exercisability upon or after a change in control as may be provided in the award agreement for such award or as may be provided in any other written agreement between the Company and the participant, but in the absence of such provision, no such acceleration will automatically occur.

21

Outstanding Equity Awards at December 31, 2024 The following tables set forth certain information about equity awards granted to our named executive officers that remain outstanding as of December 31, 2024. Option Awards

| ​                        | ​ |           ​ | ​ |             ​ | ​     |         ​ | ​ | ​          |
| ​                        |   |   Number of |   |     Number of |       |